C-type Natriuretic Peptide Inhibits Leukocyte Recruitment and Platelet-leukocyte Interactions Via Suppression of P-selectin Expression

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2005 Sep 24

PMID 16179391

Citations 36

Authors

Ramona S Scotland

Marc Cohen

Paul Foster

Matthew Lovell

Anthony Mathur

Amrita Ahluwalia

Adrian J Hobbs

Affiliations

Soon will be listed here.

Abstract

The multifaceted process of immune cell recruitment to sites of tissue injury is key to the development of an inflammatory response and involved in the pathogenesis of numerous cardiovascular disorders. We recently identified C-type natriuretic peptide (CNP) as an important endothelium-derived mediator that regulates vascular tone and protects against myocardial ischemia/reperfusion injury. Herein, we investigated whether CNP inhibits leukocyte recruitment and platelet aggregation and thereby exerts a potential antiinflammatory influence on the blood vessel wall. We assessed the effects of CNP on leukocyte-endothelial cell interactions in mouse mesenteric postcapillary venules in vivo in animals with high basal leukocyte activation (endothelial nitric oxide synthase knockout mice, eNOS(-/-)) or under acute inflammatory conditions (induced by interleukin-1beta or histamine). CNP suppressed basal leukocyte rolling in eNOS(-/-) mice in a rapid, reversible, and concentration-dependent manner. These effects of CNP were mimicked by the selective natriuretic peptide receptor-C agonist cANF(4-23). CNP also suppressed leukocyte rolling induced by IL-1beta or histamine, inhibited platelet-leukocyte interactions, and prevented thrombin-induced platelet aggregation of human blood. Furthermore, analysis of human umbilical vein endothelial cells, leukocytes, and platelets revealed that CNP selectively attenuates expression of P-selectin. Thus, CNP is a modulator of acute inflammation in the blood vessel wall characterized by leukocyte and platelet activation. These antiinflammatory effects appear to be mediated, at least in part, via suppression of P-selectin expression. These observations suggest that endothelial CNP might maintain an anti-atherogenic influence on the blood vessel wall and represent a target for therapeutic intervention in inflammatory cardiovascular disorders.

Citing Articles

Auto/Paracrine C-Type Natriuretic Peptide/Cyclic GMP Signaling Prevents Endothelial Dysfunction.

Werner F, Naruke T, Sulzenbruck L, Schafer S, Rosch M, Volker K Int J Mol Sci. 2024; 25(14).

PMID: 39063044 PMC: 11277478. DOI: 10.3390/ijms25147800.

Coronary No-Reflow after Primary Percutaneous Coronary Intervention-Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy.

Ndrepepa G, Kastrati A J Clin Med. 2023; 12(17).

PMID: 37685660 PMC: 10488607. DOI: 10.3390/jcm12175592.

Decreased level of serum NT-proCNP associates with disease severity in COVID-19.

Bojti I, Przewosnik A, Luxenburger H, Hofmann M, Neumann-Haefelin C, Esser J Respir Res. 2023; 24(1):174.

PMID: 37386635 PMC: 10311835. DOI: 10.1186/s12931-023-02469-4.

3D doppler ultrasound imaging of cerebral blood flow for assessment of neonatal hypoxic-ischemic brain injury in mice.

Shen G, Sanchez K, Hu S, Zhao Z, Zhang L, Ma Q PLoS One. 2023; 18(5):e0285434.

PMID: 37159455 PMC: 10168578. DOI: 10.1371/journal.pone.0285434.

Localization of natriuretic peptide receptors A, B, and C in healthy and diseased mouse kidneys.

Heinl E, Broeker K, Lehrmann C, Heydn R, Krieger K, Ortmaier K Pflugers Arch. 2022; 475(3):343-360.

PMID: 36480070 PMC: 9908653. DOI: 10.1007/s00424-022-02774-9.

References

Yao L, Setiadi H, Xia L, Laszik Z, Taylor F, McEver R . Divergent inducible expression of P-selectin and E-selectin in mice and primates. Blood. 1999; 94(11):3820-8. View

Fisslthaler B, Popp R, Kiss L, Potente M, Harder D, Fleming I . Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999; 401(6752):493-7. DOI: 10.1038/46816. View

Gratacap M, Herault J, Viala C, Ragab A, Savi P, Herbert J . FcgammaRIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation. Blood. 2000; 96(10):3439-46. View

Norman K, Katopodis A, Thoma G, Kolbinger F, HICKS A, Cotter M . P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo. Blood. 2000; 96(10):3585-91. View

Doi K, Ikeda T, Itoh H, Ueyama K, Hosoda K, Ogawa Y . C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization. Arterioscler Thromb Vasc Biol. 2001; 21(6):930-6. DOI: 10.1161/01.atv.21.6.930. View

Sanz M, Hickey M, Johnston B, McCafferty D, Raharjo E, Huang P . Neuronal nitric oxide synthase (NOS) regulates leukocyte-endothelial cell interactions in endothelial NOS deficient mice. Br J Pharmacol. 2001; 134(2):305-12. PMC: 1572945. DOI: 10.1038/sj.bjp.0704234. View

Ohno N, Itoh H, Ikeda T, Ueyama K, Yamahara K, Doi K . Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. Circulation. 2002; 105(14):1623-6. DOI: 10.1161/01.cir.0000014985.50017.6e. View

Hicks A, Leppanen A, Cummings R, McEver R, Hellewell P, Norman K . Glycosulfopeptides modeled on P-selectin glycoprotein ligand 1 inhibit P-selectin-dependent leukocyte rolling in vivo. FASEB J. 2002; 16(11):1461-2. DOI: 10.1096/fj.02-0075fje. View

Qian J, Haruno A, Asada Y, Nishida T, Saito Y, Matsuda T . Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries. Circ Res. 2002; 91(11):1063-9. DOI: 10.1161/01.res.0000043631.25915.e6. View

10.

Huo Y, Schober A, Forlow S, Smith D, Hyman M, Jung S . Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2002; 9(1):61-7. DOI: 10.1038/nm810. View

11.

Kalra P, Clague J, Bolger A, Anker S, Poole-Wilson P, Struthers A . Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation. 2003; 107(4):571-3. DOI: 10.1161/01.cir.0000047280.15244.eb. View

12.

Chauhan S, Nilsson H, Ahluwalia A, Hobbs A . Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor. Proc Natl Acad Sci U S A. 2003; 100(3):1426-31. PMC: 298789. DOI: 10.1073/pnas.0336365100. View

13.

Yamahara K, Itoh H, Chun T, Ogawa Y, Yamashita J, Sawada N . Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration. Proc Natl Acad Sci U S A. 2003; 100(6):3404-9. PMC: 152305. DOI: 10.1073/pnas.0538059100. View

14.

Hicks A, Nolan S, Ridger V, Hellewell P, Norman K . Recombinant P-selectin glycoprotein ligand-1 directly inhibits leukocyte rolling by all 3 selectins in vivo: complete inhibition of rolling is not required for anti-inflammatory effect. Blood. 2002; 101(8):3249-56. DOI: 10.1182/blood-2002-07-2329. View

15.

Ley K . The role of selectins in inflammation and disease. Trends Mol Med. 2003; 9(6):263-8. DOI: 10.1016/s1471-4914(03)00071-6. View

16.

Roger S, Pawlowski M, Habib A, Jandrot-Perrus M, Rosa J, Bryckaert M . Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation. FEBS Lett. 2004; 556(1-3):227-35. DOI: 10.1016/s0014-5793(03)01430-3. View

17.

Ahluwalia A, Foster P, Scotland R, McLean P, Mathur A, Perretti M . Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. Proc Natl Acad Sci U S A. 2004; 101(5):1386-91. PMC: 337062. DOI: 10.1073/pnas.0304264101. View

18.

Schachner T, Zou Y, Oberhuber A, Mairinger T, Tzankov A, Laufer G . Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts. Eur J Cardiothorac Surg. 2004; 25(4):585-90. DOI: 10.1016/j.ejcts.2003.07.013. View

19.

Shankar H, Murugappan S, Kim S, Jin J, Ding Z, Wickman K . Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses. Blood. 2004; 104(5):1335-43. DOI: 10.1182/blood-2004-01-0069. View

20.

Hobbs A, Foster P, Prescott C, Scotland R, Ahluwalia A . Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide. Circulation. 2004; 110(10):1231-5. DOI: 10.1161/01.CIR.0000141802.29945.34. View